Reduced Chance of Hearing Loss Associated with Therapeutic Drug Monitoring of Aminoglycosides in the Treatment of Multidrug-Resistant Tuberculosis. [electronic resource]
Producer: 20170920ISSN:- 1098-6596
- Adult
- Amikacin -- adverse effects
- Antitubercular Agents -- adverse effects
- Area Under Curve
- Audiometry
- Biological Availability
- Drug Administration Schedule
- Drug Dosage Calculations
- Drug Monitoring
- Extensively Drug-Resistant Tuberculosis -- blood
- Female
- Hearing Loss -- chemically induced
- Humans
- Kanamycin -- adverse effects
- Male
- Microbial Sensitivity Tests
- Mycobacterium tuberculosis -- drug effects
- Retrospective Studies
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.